A research partnership between biotechnology company Thermalin and pharmaceutical firm Sanofi for new insulin treatments for diabetes is expected to produce up to $788 million. The companies will focus on developing ways to transform insulin molecules to better treat the condition.
Research partnership aims to develop new treatments for diabetes
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.